Search Results - "Borsi, J D."

Conduct of phase I trials in children with cancer by Smith, M, Bernstein, M, Bleyer, W A, Borsi, J D, Ho, P, Lewis, I J, Pearson, A, Pein, F, Pratt, C, Reaman, G, Riccardi, R, Seibel, N, Trueworthy, R, Ungerleider, R, Vassal, G, Vietti, T

“…Future progress in the care of children with cancer requires appropriate evaluations of promising new agents for pediatric indications, beginning with…”
Get more information

Results of a Multilateral Approach to Donation–Transplantation Process in Hungary in the Past 2 Years by Borsi, J.D., Borka, P., Tornai, E., Mihály, S., Deme, O., Mina, A.

“…Hungarotransplant Public Service Corporation, the national organ exchange organization, was established in 2001. The assessment of donation- and…”
Get full text

Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours by Csáki, C., Ferencz, T., Schuler, D., Borsi, J.D.

“…This prospective, randomised pilot study was designed to evaluate safety, feasibility and efficacy of recombinant human erythropoietin (rhEPO) in the…”
Get full text

A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia by Borsi, J D, Moe, P J

“…Concentrations of methotrexate have been determined in the serum and cerebrospinal fluid after 406 infusions of methotrexate to 58 children with acute…”
Get more information

Childhood leukemia and statistical characteristics in 0- to 18-year-old patients in Hungary, diagnosed between 1988 and 1992 by Apjok, E, Koos, R, Borsi, J D, Schuler, D

“…A population-based cancer registry for childhood leukemia was started in Hungary in 1971. Data processing and analysis have been done at the Second Department…”
Get more information

Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatin by Borsi, J D, Csaki, C, Ferencz, T, Oster, W

“…The first report on the administration of the chemoprotective agent Ethyol (amifostine) in conjunction with high dose carboplatin to a patient in the…”
Get more information

Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children by Borsi, J D, Moe, P J

“…The prognostic value of systemic clearance of methotrexate (MTX) has been evaluated in 58 children with acute lymphoblastic leukemia, receiving altogether 380…”
Get more information

Apoptosis as a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukemia by Schuler, D, Szende, B, Borsi, J D, Marton, T, Bocsi, J, Magyarossy, E, Koós, R, Csóka, M

“…Apoptosis (programmed cell death) is a physiologic phenomenon wherein the dying cell plays an active part in its own destruction. It has an important role in…”
Get more information

Proteinuria due to suboptimal hydration with high-dose methotrexate therapy by KOVACS, G. T, PAAL, C, SOMLO, P, KOOS, R, SCHULER, D, BORSI, J. D

“…One of the major complications after high-dose methotrexate (HDMTX) infusions is renal damage. We investigated the occurrence of proteinuria after HDMTX…”
Get full text

Pediatric Oncology Outreach to Hungary: A Registry of Childhood Malignancies by APJOK, ENIKÖ, BORSI, JOSEPH D., KOÓS, ROZÁLIA, SCHULER, DEZSÖ, BOLINGER, ROBERT E., BOYSEN, CATHY D., BAKER, ARIEL B., HOLMES, FREDERICK F.

Get full text

Human recombinant granulocyte-macrophage colony-stimulating factor in pediatric oncology practice by Ferencz, T, Csaki, C, Schuler, D, Borsi, J D

“…This paper reports preliminary experiences with human recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) in children with malignant diseases…”
Get more information

Safety of Dexrazoxane in Children with All Undergoing Anthracycline Therapy: Preliminary Results of a Prospective Pilot Study by Schuler, D., Horváth, E., Koós, R., Kajtár, P., Zimonyi, I., Virág, I., Masát, P., Garami, M., Borsi, J. D.

Get full text

Evaluation of serious adverse events in patients treated with protocols including methotrexate infusions by Seidel, H, Moe, P J, Nygaard, R, Nygaard, K, Brede, W, Borsi, J D

“…During the period 1979 to 1992 we treated 141 children for various malignant diseases with protocols including methotrexate (MTX) infusions in doses ranging…”
Get more information

Pharmacokinetic studies on Elobromol in children with brain tumors by Paál, C, Erdélyi-Tóth, V, Pap, E, Csáki, C, Ferencz, T, Schuler, D, Borsi, J D

“…Systemic pharmacokinetics of high dose (500 mg/m2), orally administered Elobromol (dibromodulcitol, DBD) were studied in 16 chemotherapeutic courses…”
Get more information

Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia by BORSI, J. D, REVESZ, T, SCHULER, D

“…Pharmacokinetic studies of methotrexate have been carried out in 21 children with acute lymphoblastic leukemia diagnosed in 1981. Children were treated with…”
Get full text

Pharmacokinetics of folinic acid in children with acute lymphoblastic leukemia by Borsi, J D, Sagen, E, Romslo, I, Moe, P J

Get more information

Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison by BORSI, J. D, SCHULER, D, MOE, P. J

“…The pharmacokinetics of 8 g/m2 methotrexate (MTX) was compared following short (6 h) and long (24 h) infusions of the drug to 11 children with osteogenic…”
Get full text

Rescue after intermediate and high-dose methotrexate: background, rationale, and current practice by Borsi, J D, Sagen, E, Romslo, I, Moe, P J

“…Pharmacologic rescue methods used in combination with intermediate and high-dose methotrexate therapy are reviewed, with special emphasis on rescue with…”
Get more information

7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia by BORSI, J. D, SAGEN, E, ROMSLO, I, SLOÊRDAL, L, MOE, P. J

“…Concentrations of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) were determined by HPLC in the serum and cerebrospinal fluid (CSF) of 29 children…”
Get full text

PharmCalc: program for the calculation of clinical pharmacokinetic parameters of methotrexate by BORSI, J. D, KLEPP, O, MOE, P. J

“…A new program package (PharmCalc) has been developed for the calculation of basic pharmacokinetic parameters (half-time, systemic clearance, renal clearance,…”
Get full text